Cargando…
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC
Homoharringtonine, a plant alkaloid, has been reported to suppress protein synthesis and has been approved by the US Food and Drug Administration for the treatment of chronic myeloid leukemia. Here we show that in acute myeloid leukemia (AML), homoharringtonine potently inhibits cell growth/viabilit...
Autores principales: | Li, Chenying, Dong, Lei, Su, Rui, Bi, Ying, Qing, Ying, Deng, Xiaolan, Zhou, Yile, Hu, Chao, Yu, Mengxia, Huang, Hao, Jiang, Xi, Li, Xia, He, Xiao, Zou, Dongling, Shen, Chao, Han, Li, Sun, Miao, Skibbe, Jennifer, Ferchen, Kyle, Qin, Xi, Weng, Hengyou, Huang, Huilin, Song, Chunxiao, Chen, Jianjun, Jin, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939512/ https://www.ncbi.nlm.nih.gov/pubmed/30975912 http://dx.doi.org/10.3324/haematol.2018.208835 |
Ejemplares similares
-
TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
por: Lio, Chan-Wang J., et al.
Publicado: (2019) -
ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia
por: Wang, Yungui, et al.
Publicado: (2017) -
Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns
por: Adam, Sabrina, et al.
Publicado: (2022) -
Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms
por: Seethy, Ashikh A., et al.
Publicado: (2023) -
The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
por: Li, Xia, et al.
Publicado: (2017)